N. Agmon-levin, J. Damoiseaux, C. Kallenberg, U. Sack, T. Witte et al., International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of the rheumatic diseases, vol.73, pp.17-23, 2013.

D. H. Solomon, A. J. Kavanaugh, and P. H. Schur, Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing, Arthritis and rheumatism, vol.47, issue.4, pp.434-478, 2002.

N. Agmon-levin, Y. Shapira, C. Selmi, O. Barzilai, M. Ram et al., A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis, Journal of autoimmunity, vol.34, issue.1, pp.55-63, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01163300

R. L. Ochs, T. W. Stein, C. L. Peebles, R. F. Gittes, and E. M. Tan, Autoantibodies in interstitial cystitis. The Journal of urology, vol.151, pp.587-92, 1994.

M. Daugaard, A. Baude, K. Fugger, L. K. Povlsen, H. Beck et al., LEDGF (p75) promotes DNA-end resection and homologous recombination, Nature structural & molecular biology, vol.19, issue.8, pp.803-813, 2012.

M. Miyara, R. Albesa, J. L. Charuel, M. El-amri, M. J. Fritzler et al., Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort, Clinical & developmental immunology, p.703759, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01548814

P. Central and P. , , p.3580898

R. L. Ochs, Y. Muro, Y. Si, H. Ge, E. K. Chan et al., Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions, The Journal of allergy and clinical immunology, vol.105, issue.6, pp.1211-1231, 2000.

M. Okamoto, Y. Ogawa, A. Watanabe, K. Sugiura, Y. Shimomura et al., Autoantibodies to DFS70/ LEDGF are increased in alopecia areata patients, Journal of autoimmunity, vol.23, issue.3, pp.257-66, 2004.

T. Shinohara, D. P. Singh, L. T. Chylack, and . Review, Journal of ocular pharmacology and therapeutics: the official journal of the Association for, Ocular Pharmacology and Therapeutics, vol.16, issue.2, pp.181-91, 2000.

K. Yamada, S. Senju, T. Shinohara, T. Nakatsura, Y. Murata et al., Humoral immune response directed against LEDGF in patients with VKH, Immunology letters, vol.78, issue.3, pp.161-169, 2001.

A. Watanabe, M. Kodera, K. Sugiura, T. Usuda, E. M. Tan et al., Anti-DFS70 antibodies in 597 healthy hospital workers, Arthritis and rheumatism, vol.50, issue.3, pp.892-900, 2004.

H. A. Mariz, E. I. Sato, S. H. Barbosa, S. H. Rodrigues, A. Dellavance et al., Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases, Epub 2010/10/19, vol.63, pp.191-200, 2011.

, National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing. London: Royal College of Physicians (UK)National Clinical Guideline Centre, 2012.

E. M. Tan, T. E. Feltkamp, J. S. Smolen, B. Butcher, R. Dawkins et al., Range of antinuclear antibodies in "healthy" individuals. Arthritis and rheumatism, vol.40, pp.1601-1612, 1997.

V. R. Arruda, P. M. Von-zuben, L. C. Chiaparini, J. M. Annichino-bizzacchi, and F. F. Costa, The mutation Ala677->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis, Thrombosis and haemostasis, vol.77, issue.5, pp.818-839, 1997.

I. Martinelli, E. Taioli, I. Cetin, A. Marinoni, S. Gerosa et al., Mutations in coagulation factors in women with unexplained late fetal loss, The New England journal of medicine, vol.343, issue.14, pp.1015-1023, 2000.

S. R. Poort, F. R. Rosendaal, P. H. Reitsma, and R. M. Bertina, A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, issue.10, pp.3698-703, 1996.

P. M. Ridker, C. H. Hennekens, K. Lindpaintner, M. J. Stampfer, P. R. Eisenberg et al., Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England journal of medicine, vol.332, pp.912-919, 1995.

D. Stefano, V. Martinelli, I. Mannucci, P. M. Paciaroni, K. Chiusolo et al., The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. The New England journal of medicine, vol.341, pp.801-807, 1999.

M. J. Kupferminc, A. Eldor, N. Steinman, A. Many, A. Bar-am et al., Increased frequency of genetic thrombophilia in women with complications of pregnancy. The New England journal of medicine, vol.340, pp.9-13, 1999.

F. E. Preston, F. R. Rosendaal, I. D. Walker, E. Briet, E. Berntorp et al., Increased fetal loss in women with heritable thrombophilia, Lancet, vol.348, issue.9032, pp.913-919, 1996.

M. Mahler and M. J. Fritzler, Epitope specificity and significance in systemic autoimmune diseases, Annals of the New York Academy of Sciences, vol.1183, pp.267-87, 2010.

L. M. Stinton and M. J. Fritzler, A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders, Autoimmunity reviews, vol.7, issue.1, pp.77-84, 2007.

F. Goldblatt, O. Neill, and S. G. , Clinical aspects of autoimmune rheumatic diseases, Lancet, vol.382, issue.9894, pp.797-808, 2013.

S. Miyakis, M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), JTH, vol.4, issue.2, pp.295-306, 2006.

A. Tripodi, V. Chantarangkul, I. Martinelli, P. Bucciarelli, and P. M. Mannucci, A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism, Blood, vol.104, issue.12, pp.3631-3635, 2004.

G. Biino, L. Portas, F. Murgia, S. Vaccargiu, D. Parracciani et al., A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thrombosis research, vol.129, pp.8-13, 2012.

J. L. Kujovich, American journal of obstetrics and gynecology, vol.191, pp.412-436, 2004.

H. Ge, Y. Si, and R. G. Roeder, Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation, The EMBO journal, vol.17, issue.22, pp.6723-6732, 1998.

D. P. Singh, N. Ohguro, L. T. Chylack, and T. Shinohara, Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses, vol.40, pp.1444-51, 1999.

F. F. Chen, W. H. Lin, S. C. Lin, J. H. Kuo, H. Y. Chu et al., Significance of heparin binding to basic residues in homologous to the amino terminus of hepatoma-derived growth factor and related proteins, Glycobiology, vol.22, issue.5, pp.649-61, 2012.

N. Fatma, D. P. Singh, T. Shinohara, and L. T. Chylack, Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus, Investigative ophthalmology & visual science, vol.41, issue.9, pp.2648-57, 2000.

J. S. Levine, D. W. Branch, and J. Rauch, The antiphospholipid syndrome. The New England journal of medicine, vol.346, pp.752-63, 2002.

J. G. Kelton and T. E. Warkentin, Heparin-induced thrombocytopenia: a historical perspective, Blood, vol.112, issue.7, pp.2607-2623, 2008.

J. H. Yoon and I. K. Jang, Heparin-induced thrombocytopenia in cardiovascular patients: pathophysiology, diagnosis, and treatment, Cardiology in review, vol.19, issue.3, pp.143-53, 2011.

S. Rantapaa-dahlqvist, B. A. De-jong, E. Berglin, G. Hallmans, G. Wadell et al., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis and rheumatism, vol.48, issue.10, pp.2741-2750, 2003.

A. G. Ziegler, M. Rewers, O. Simell, T. Simell, J. Lempainen et al., Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children, Jama, vol.309, issue.23, pp.2473-2482, 2013.

M. R. Arbuckle, M. T. Mcclain, M. V. Rubertone, R. H. Scofield, G. J. Dennis et al., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England journal of medicine, vol.349, pp.1526-1559, 2003.

Y. Ogawa, K. Sugiura, A. Watanabe, M. Kunimatsu, M. Mishima et al., Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain, Journal of autoimmunity, vol.23, issue.3, pp.221-252, 2004.